Top section
Top section
Deal could include $950m of bonds
Upper mid-market firms eschew ‘exciting’ stories as cracks emerge in European private credit
Pharmaceuticals and energy transition also ripe sectors for M&A
More articles
More articles
More articles
-
The additional €5bn of repayments could be 'material' for triple-A demand -
Bankers give Galderma and Douglas a decent chance of relying on organic demand
-
Despite a few tighter prints last week, pricing is unlikely to compress much further
-
Term loans are back on the agenda in a “borrower-friendly market”
-
While we may not see the immediate benefits of new private credit fund regulation now, we might see them eventually. We hope not to see them at all
-
Investec has grown its private equity advisory offering in ‘transformational moment’ for PE
Sub-sections
shared comment list
